These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 9379450
1. 17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha). Ling YZ, Li JS, Liu Y, Kato K, Klus GT, Brodie A. J Med Chem; 1997 Sep 26; 40(20):3297-304. PubMed ID: 9379450 [Abstract] [Full Text] [Related]
2. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer. Njar VC, Kato K, Nnane IP, Grigoryev DN, Long BJ, Brodie AM. J Med Chem; 1998 Mar 12; 41(6):902-12. PubMed ID: 9526564 [Abstract] [Full Text] [Related]
3. Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17 alpha-hydroxylase/C17,20-lyase. Li JS, Li Y, Son C, Brodie AM. J Med Chem; 1996 Oct 11; 39(21):4335-9. PubMed ID: 8863811 [Abstract] [Full Text] [Related]
8. Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17). Hartmann RW, Hector M, Wachall BG, Palusczak A, Palzer M, Huch V, Veith M. J Med Chem; 2000 Nov 16; 43(23):4437-45. PubMed ID: 11087568 [Abstract] [Full Text] [Related]
10. Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer. Potter GA, Barrie SE, Jarman M, Rowlands MG. J Med Chem; 1995 Jun 23; 38(13):2463-71. PubMed ID: 7608911 [Abstract] [Full Text] [Related]
12. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)). Owen CP, Shahid I, Olusanjo MS, Patel CH, Dhanani S, Ahmed S. J Steroid Biochem Mol Biol; 2008 Jul 23; 111(1-2):117-27. PubMed ID: 18620055 [Abstract] [Full Text] [Related]
13. Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17. Wächter GA, Hartmann RW, Sergejew T, Grün GL, Ledergerber D. J Med Chem; 1996 Feb 16; 39(4):834-41. PubMed ID: 8632407 [Abstract] [Full Text] [Related]
14. 17 beta-(cyclopropylamino)-androst-5-en-3 beta-ol, a selective mechanism-based inhibitor of cytochrome P450(17 alpha) (steroid 17 alpha-hydroxylase/C17-20 lyase). Angelastro MR, Laughlin ME, Schatzman GL, Bey P, Blohm TR. Biochem Biophys Res Commun; 1989 Aug 15; 162(3):1571-7. PubMed ID: 2788415 [Abstract] [Full Text] [Related]
17. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors. Numazawa M, Kamiyama T, Tachibana M, Oshibe M. J Med Chem; 1996 May 24; 39(11):2245-52. PubMed ID: 8667367 [Abstract] [Full Text] [Related]